Skip to main content
ANIP
NASDAQ Life Sciences

FDA Approves ANI's Everolimus Oral Suspension, Expanding Oncology Portfolio

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$78.44
Mkt Cap
$1.79B
52W Low
$69.58
52W High
$97.52
52W Position info
13% above low
Off High info
20% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

ANIP is trading near its 52-week low of $69.58 (13% above the low).

Summary

The FDA approved ANI Pharmaceuticals' Everolimus Tablets for Oral Suspension, adding a new oncology product to its portfolio. This is the first report of this approval in the timeline. The approval expands ANI's commercial offerings and provides a new revenue stream, though specific sales projections are not disclosed. The company recently reported record Q2 revenue of $266 million, up 25.9% year-over-year, and this approval supports its growth strategy. Investors will watch for launch timing and potential contribution to future earnings.

At the time of this announcement, ANIP was trading at $78.44 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $69.58 to $97.52. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

ANIP - Latest Insights

ANIP
Nov 05, 2026, 5:13 PM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $69.00
Real-time Price: $68.55 info
Change: -$0.450 (-0.65%) info
Market Cap: $1.558B info
ANIP
Nov 05, 2026, 6:58 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $75.00
Real-time Price: $68.55 info
Change: -$6.45 (-9%) info
Market Cap: $1.558B info
ANIP
Nov 05, 2026, 6:56 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $71.72
Real-time Price: $68.55 info
Change: -$3.17 (-4%) info
Market Cap: $1.558B info
ANIP
Nov 05, 2026, 6:51 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $72.00
Real-time Price: $68.55 info
Change: -$3.45 (-5%) info
Market Cap: $1.558B info
ANIP
Nov 05, 2026, 1:33 AM EST
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $72.00
Real-time Price: $68.55 info
Change: -$3.45 (-5%) info
Market Cap: $1.558B info